SF
Saul Faust
Research areas: Medicine · Infectious Diseases · Bacterial Infections and Vaccines · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies
0000-0003-3410-7642
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (383)
- The platform trial in COVID-19 priming and BOOsting (PICOBOO): the reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults Save
- Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK Save
- Infant RSV Hospitalisations Before and After Introduction of RSV Prophylaxis Programs in Spain and the United Kingdom, June 2022-May 2025 Save
- Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trial Save
- ChAdOx1 nCoV-19 coronavirus vaccine: long-term safety and immunological responses Save
- The Platform trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults Save
- BPZE1 vaccination induces IL-17 + and IL-22 + CD4 + T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation Save
- Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialAn open-label, dose-escalation, first-in-human trial assessing safety and immunogenicity of mRNA-based mpox vaccine candidate BNT1… Save
- Mid-infrared germanium-on-silicon waveguide sensor for therapeutic drug monitoring of phenytoin Save
- Quality of life of X-linked agammaglobulinemia patients in the United Kingdom Save
- Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection study Save
- Surviving Sepsis Campaign international guidelines for the management of sepsis and septic shock in children 2026 Save
- MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study Save
- Controlled human infection of healthy adults with lyophilized Neisseria lactamica induces asymptomatic, immunogenic nasopharyngeal carriage in the United Kingdom and Mali Save
- Enablers and barriers to participation in vaccine trials: a narrative synthesis Save
- Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): a randomised controlled non-inferiority trial Save
- Evaluating antibiotic medications delivered through elastomeric devices in a paediatric population: a systematic review Save
- Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis Save
- Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine Save
- Changes in carriage and serotype diversity of Streptococcus pneumoniae and other respiratory pathobionts in the UK between pre-PCV13 (2006-10), early-PCV13 (2010-12) and late-PCV13 (2012-23) periods Save